G
6.67
-0.11 (-1.62%)
| Previous Close | 6.78 |
| Open | 6.68 |
| Volume | 2,623 |
| Avg. Volume (3M) | 18,440 |
| Market Cap | 8,453,158 |
| 52 Weeks Range | |
| Earnings Date | 9 Aug 2023 - 14 Aug 2023 |
| Profit Margin | 52.13% |
| Operating Margin (TTM) | -1,875.34% |
| Diluted EPS (TTM) | -4.11 |
| Quarterly Revenue Growth (YOY) | -8.40% |
| Current Ratio (MRQ) | 16.67 |
| Operating Cash Flow (TTM) | -3.92 M |
| Levered Free Cash Flow (TTM) | 1.38 M |
| Return on Assets (TTM) | -15.53% |
| Return on Equity (TTM) | -50.26% |
AIStockmoo Score
| Value 60% | 0.0 |
| Weak profitability. Ample short-term liquidity. Positive cash flow. info | |
| From our AI Insight report's view of expected return against risk. info | NA |
| Relative Valuation info | NA |
| Implied Growth info | NA |
| Valuation History info | NA |
| Return on Capital info | NA |
| Holdings' Value info | NA |
| Risk Premium info | NA |
| Market Valuation info | NA |
| Timing | NA |
| From our AI technical analysis of the chart. info | NA |
| Trend Strength info | NA |
| Technical Setup info | NA |
| Candle Patterns info | NA |
| Medium-Term Trend info | NA |
| Sentiment 40% | 0.0 |
| No recent price targets, so based on how targets have been revised. info | |
| Holdings' Sentiment info | NA |
| News Mood info | NA |
| Smart Money | NA |
| Insider Activity info | NA |
| Institutional Flow info | NA |
| Short Interest info | NA |
| Market and sector conditions are poor. | |
| Market environment cautious. info | |
| Sector outperforming the market. | |
| No pillar has a clear reading, so the score is unchanged. | |
| Not in score | |
| Earnings per share have gone up and down. Made a loss in recent years. info | |
| Price Volatility info | NA |
| No clear trend across the short, medium and long term. info | |
| No clear signal from support and resistance. info | |
| Final Score | 0.00 |
Market Trend
| Short Term | Medium Term | ||
| Industry | Drug Manufacturers - Specialty & Generic (US) | Mixed | Mixed |
| Drug Manufacturers - Specialty & Generic (Global) | Mixed | Mixed | |
| Stock | Guardion Health Sciences, Inc. | - | - |
Similar Stocks
| Stock | Market Cap | DY | P/E (TTM) | P/B | Score |
|---|---|---|---|---|---|
| GHSI | 8 M | - | - | - | 0.0 |
| SUPN | 6 B | 27.84% | - | 1.59 | -1.0 |
| ANIP | 2 B | - | 13.74 | 2.57 | -0.1 |
| COLL | 783 M | - | 23.13 | 2.72 | 0.1 |
| TKNO | 480 M | - | - | - | 0.8 |
| AQST | 435 M | - | - | - | -1.7 |
Select this tab to load the latest available analysis.
|
Guardion Health Sciences Inc clinical nutrition company that develops and distributes clinically supported dietary supplements and medical foods. It offers a portfolio of science-based, clinically supported products designed to support consumers, healthcare professionals and providers, and their patients by supporting bone health, eye health, cardiovascular health, and brain health through nutrients such as Calcium, Vitamin D, Vitamin K, Carotenoids, and Omega-3s. |
|
| Sector | Healthcare |
| Industry | Drug Manufacturers - Specialty & Generic |
| Investment Style | Small Value |
| % Held by Insiders | 1.30% |
| % Held by Institutions | 21.09% |
No data within this time range.
No data within this time range.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2026 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |